Inj. Natrii Chlorati Polpharma (Sodium Chloride)

The sodium chloride solution provides Na⁺ and Cl⁻ ions that expand the extracellular fluid volume, increase plasma osmolality, and help restore the normal balance of electrolytes. This supports blood pressure, tissue perfusion, and cellular function, especially when patients have lost fluids or have low serum sodium.

The prescribed dose of Inj. Natrii Chlorati Polpharma is individualized by the treating clinician based on the patient’s fluid status, electrolyte levels, body weight, and the clinical indication. Dosage calculations consider the desired rate of volume expansion and target serum sodium concentration.

Safety data for sodium chloride injection in pregnancy and lactation are limited, and the product does not have a specific pregnancy category. Clinicians should weigh the potential benefits against any possible risks and use the product only if clearly indicated by a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Inj. Natrii Chlorati Polpharma is essentially a sterile sodium chloride solution similar to normal saline (0.9% NaCl). Both provide isotonic fluid replacement, but formulation specifics, packaging, and regulatory status may differ. Clinicians choose the product that best fits their supply chain, labeling requirements, and institutional preferences.

Store Inj. Natrii Chlorati Polpharma at 2‑8 °C (refrigerated). Keep the vials in the original packaging, protect them from light, and do not freeze or shake the product. Maintaining the cold chain preserves solution stability and sterility.

The product is administered intravenously, either as a direct infusion or added to an IV line as a diluent for other medications. Administration should follow aseptic technique, using appropriate infusion sets, and the rate should be adjusted according to the patient’s clinical condition and physician orders.

Serious risks include severe hypernatremia, anaphylactic reactions, volume overload leading to pulmonary edema, cardiac arrhythmias from electrolyte disturbances, and acute renal failure in susceptible patients. Prompt recognition of symptoms and regular monitoring of electrolytes and fluid status are essential.

Patients with known hypersensitivity to sodium chloride solutions, those with uncontrolled severe hypernatremia, or individuals at high risk of fluid overload (e.g., severe heart failure, uncontrolled hypertension) should not receive this injection unless a clinician determines that benefits outweigh the risks.